Cargando…
Integrin α3/α6 and αV are implicated in ADAM15-activated FAK and EGFR signalling pathway individually and promote non-small-cell lung cancer progression
Disintegrin-metalloproteinase 15(ADAM15), a member of disintegrin metalloproteinases (ADAMs), plays important roles in various cancer types. However, the underlying ADAM15 functioning in lung cancer is still unclear. In the present study, we find that ADAM15 regulates the epidermal growth factor rec...
Autores principales: | Zhou, Jieqi, Wang, Anqi, Cai, Tingting, Li, Yue, Du, Wenwen, Zhang, Yang, Zhang, Ruochen, Zhang, Weijie, Zhu, Jianjie, Zeng, Yuanyuan, Huang, Jian-an, Liu, Zeyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124216/ https://www.ncbi.nlm.nih.gov/pubmed/35597804 http://dx.doi.org/10.1038/s41419-022-04928-0 |
Ejemplares similares
-
Abnormally activated OPN/integrin αVβ3/FAK signalling is responsible for EGFR-TKI resistance in EGFR mutant non-small-cell lung cancer
por: Fu, Yulong, et al.
Publicado: (2020) -
CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer
por: Zhu, Jianjie, et al.
Publicado: (2021) -
FTO facilitates cancer metastasis by modifying the m(6)A level of FAP to induce integrin/FAK signaling in non-small cell lung cancer
por: Gao, Lirong, et al.
Publicado: (2023) -
The regulation of CPNE1 ubiquitination by the NEDD4L is involved in the pathogenesis of non-small cell lung cancer
por: Zhang, Ruochen, et al.
Publicado: (2021) -
CPNE1 promotes non-small cell lung cancer progression by interacting with RACK1 via the MET signaling pathway
por: Wang, Anqi, et al.
Publicado: (2022)